219 related articles for article (PubMed ID: 11152232)
1. Impact and management of hyperlipidemia posttransplantation.
Fellström B
Transplantation; 2000 Dec; 70(11 Suppl):SS51-7. PubMed ID: 11152232
[TBL] [Abstract][Full Text] [Related]
2. New-onset diabetes after transplantation.
Marchetti P
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S194-201. PubMed ID: 15093805
[TBL] [Abstract][Full Text] [Related]
3. Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials.
Demopoulos L; Polinsky M; Steele G; Mines D; Blum M; Caulfield M; Adamkovic A; Liu Q; Harler MB; Hahn C; Singh A
Transplant Proc; 2008 Jun; 40(5):1407-10. PubMed ID: 18589118
[TBL] [Abstract][Full Text] [Related]
4. Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
Valantine H
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S187-93. PubMed ID: 15093804
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of antilipidemic therapies in chronic renal allograft failure.
Wanner C; Bartens W; Galle J
Kidney Int Suppl; 1995 Dec; 52():S60-2. PubMed ID: 8587286
[TBL] [Abstract][Full Text] [Related]
6. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
Ward HJ
J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
[TBL] [Abstract][Full Text] [Related]
7. [Hypertension in solid organ transplants].
Glatz N; Wuerzner G; Pruijm M; Golshayan D; Burnier M
Rev Med Suisse; 2009 Sep; 5(216):1771-4, 1776-7. PubMed ID: 19807050
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients.
Manzarbeitia C; Reich DJ; Rothstein KD; Braitman LE; Levin S; Munoz SJ
Liver Transpl; 2001 Feb; 7(2):93-9. PubMed ID: 11172391
[TBL] [Abstract][Full Text] [Related]
9. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD
Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hyperlipidemia in cardiac transplant recipients.
Bilchick KC; Henrikson CA; Skojec D; Kasper EK; Blumenthal RS
Am Heart J; 2004 Aug; 148(2):200-10. PubMed ID: 15308989
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular disease after renal transplantation].
Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
G Ital Nefrol; 2004; 21 Suppl 26():S53-66. PubMed ID: 15732047
[TBL] [Abstract][Full Text] [Related]
12. Impact of fluvastatin on hyperlipidemia after renal transplantation.
Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
[TBL] [Abstract][Full Text] [Related]
13. A long-term study on hyperlipidemia in stable renal transplant recipients.
Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM
Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
[TBL] [Abstract][Full Text] [Related]
14. Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.
Kreis HA; Ponticelli C
Transplantation; 2001 Jun; 71(11 Suppl):SS5-9. PubMed ID: 11583489
[TBL] [Abstract][Full Text] [Related]
15. From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.
Valantine H; Zuckermann A
J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S185-90; discussion S210-1. PubMed ID: 15774320
[TBL] [Abstract][Full Text] [Related]
16. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
[TBL] [Abstract][Full Text] [Related]
17. Correlation of C0 and C2 levels with lipid profiles in adolescent renal transplant recipients in the early and late posttransplant periods.
Soylu A; Kavukçu S; Türkmen MA; Kasap B; Soylu A; Bora S; Gülay H
Transplant Proc; 2006 Jun; 38(5):1286-9. PubMed ID: 16797283
[TBL] [Abstract][Full Text] [Related]
18. Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity.
Reuben A
Liver Transpl; 2001 Nov; 7(11 Suppl 1):S13-21. PubMed ID: 11689772
[TBL] [Abstract][Full Text] [Related]
19. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.
Puliyanda DP; Amet N; Dhawan A; Hilo L; Radha RK; Bunnapradist S; Czer L; Martin P; Jordan S; Toyoda M
Clin Transplant; 2006; 20(3):289-94. PubMed ID: 16824143
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and nutritional complications of renal transplantation.
Dumler F; Kilates C
J Ren Nutr; 2007 Jan; 17(1):97-102. PubMed ID: 17198943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]